Anti-CENP-B antibodies are associated with oocyte maturation and embryo development in IVF/ICSI patients

Xi min Zhang,Ruo chun Lian,Rong Lin,Su Dai,Pei yao Li,Meng Liu
DOI: https://doi.org/10.1016/j.jri.2023.104096
IF: 3.993
2023-09-01
Journal of Reproductive Immunology
Abstract:Objective Toinvestigate the effect of anti-CENP-B antibodies on oocyte maturation and embryo development in IVF/ICSI patients. Design Retrospective case-control study. Methods This study included 8856 patients who underwent IVF/ICSI at Shenzhen Zhongshan Urology Hospital from January 2017 to November 2019, and met the following criteria: (1) aged under 40; (2) patient's AMH ≥ 1.2ng/mL; (3) no history of ovarian surgery, radiotherapy or chemotherapy. The anti-CENP-B antibodies was tested by using indirect immnnofluotesent method. Based on the test results, the patients were divided into anti-CENP-B antibodies positive group(n=77) and anti-CENP-B antibodies negative group(n=8779). Baseline data and outcome measures were compared between the two groups. Main Outcome Measure(s) Metaphase II oocyte rate, embryo cleavage rate, percentage of day 3 available embryo, day 3 high quality embryo rate, blastocyst formation rate, available blastocyst formation rate, high quality blastocyst formation rate. Result(s) There was no significant difference in the rate of high-quality blastocyst formation(21.54% vs 25.23%, P=0.061). However, the MII oocyte rate (85.12% vs 88.29%, P=0.002), embryo cleavage rate (94.34% vs 96.79%, P=0.000), percentage of day 3 available embryo (58.77% vs 73.54%, P=0.000), day 3 high quality embryo rate (44.01% vs 59.20%, P=0.000), blastocyst formation rate(45.12% vs 53.70%, P=0.000)and available blastocyst formation rate (40.65% vs 48.16%, P=0.001) were much lower in the anti-CENP-B antibodies positive group than anti-CENP-B antibodies negative group. Conclusion(s) Anti-CENP-B antibodies may affect oocyte maturity and embryonic development in IVF/ICSI cycles, and positivity may be the cause of reproductive failure during IVF/ICSI treatment.
immunology,reproductive biology
What problem does this paper attempt to address?